Cargando…

Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway

BACKGROUND: Levetiracetam (LEV) is an antiepileptic drug that promotes recovery of neurological function by alleviating inflammatory reactions. However, it is not known whether it can improve secondary brain injury after intracerebral hemorrhage (ICH). The aim of this study was to determine whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jing, Zhou, Han, Lu, Donglin, Wang, Zixuan, Liu, HengJian, Sun, Yuqi, Xu, Jinxiang, Feng, Yugong, Xing, Ang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174898/
https://www.ncbi.nlm.nih.gov/pubmed/32289810
http://dx.doi.org/10.12659/MSM.922741
_version_ 1783524718705377280
author Xiong, Jing
Zhou, Han
Lu, Donglin
Wang, Zixuan
Liu, HengJian
Sun, Yuqi
Xu, Jinxiang
Feng, Yugong
Xing, Ang
author_facet Xiong, Jing
Zhou, Han
Lu, Donglin
Wang, Zixuan
Liu, HengJian
Sun, Yuqi
Xu, Jinxiang
Feng, Yugong
Xing, Ang
author_sort Xiong, Jing
collection PubMed
description BACKGROUND: Levetiracetam (LEV) is an antiepileptic drug that promotes recovery of neurological function by alleviating inflammatory reactions. However, it is not known whether it can improve secondary brain injury after intracerebral hemorrhage (ICH). The aim of this study was to determine whether LEV can reduce early inflammatory response after ICH in rats. MATERIAL/METHODS: An in vitro model of early inflammation was created by treating microglia cells with lipopolysaccharide (LPS). After exposure to various concentrations of LEV, the expression levels of NF-κB and STAT3 and inflammatory factors such as interleukin (IL)-1β and tumor necrosis factor (TNF)-α in microglia were detected. In vivo, autologous blood was used to induce the rat ICH model. The effects of LEV on post-cerebral hemorrhagic inflammatory response were examined using neurobehavioral tests, FJC staining, brain water content testing, and analysis of protein expression levels of NF-κB, JAK2, STAT3, and inflammatory factors. RESULTS: LEV treatment significantly reduced the expression of inflammatory factors and protein expression levels of NF-κB and STAT3 in LPS-treated microglia cells (P<0.05). In male Sprague-Dawley (SD) rats, LEV treatment markedly decreased the volume of hematoma and the number of degenerative neurons (P<0.05). It also improved the neurological function and relieved brain edema. The protein expression levels of NF-κB, JAK2, and STAT3 were significantly lower in the ICH+LEV group than in the control group (P<0.05). CONCLUSIONS: Our study suggests that treatment with LEV alleviates early inflammatory responses induced by ICH. Mechanistically, LEV inhibited the JAK2-STAT3 signaling pathway and reduced neuronal injury around the hematoma, and ameliorated brain edema, all of which promoted recovery of nerve function after hemorrhage.
format Online
Article
Text
id pubmed-7174898
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71748982020-04-27 Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway Xiong, Jing Zhou, Han Lu, Donglin Wang, Zixuan Liu, HengJian Sun, Yuqi Xu, Jinxiang Feng, Yugong Xing, Ang Med Sci Monit Animal Study BACKGROUND: Levetiracetam (LEV) is an antiepileptic drug that promotes recovery of neurological function by alleviating inflammatory reactions. However, it is not known whether it can improve secondary brain injury after intracerebral hemorrhage (ICH). The aim of this study was to determine whether LEV can reduce early inflammatory response after ICH in rats. MATERIAL/METHODS: An in vitro model of early inflammation was created by treating microglia cells with lipopolysaccharide (LPS). After exposure to various concentrations of LEV, the expression levels of NF-κB and STAT3 and inflammatory factors such as interleukin (IL)-1β and tumor necrosis factor (TNF)-α in microglia were detected. In vivo, autologous blood was used to induce the rat ICH model. The effects of LEV on post-cerebral hemorrhagic inflammatory response were examined using neurobehavioral tests, FJC staining, brain water content testing, and analysis of protein expression levels of NF-κB, JAK2, STAT3, and inflammatory factors. RESULTS: LEV treatment significantly reduced the expression of inflammatory factors and protein expression levels of NF-κB and STAT3 in LPS-treated microglia cells (P<0.05). In male Sprague-Dawley (SD) rats, LEV treatment markedly decreased the volume of hematoma and the number of degenerative neurons (P<0.05). It also improved the neurological function and relieved brain edema. The protein expression levels of NF-κB, JAK2, and STAT3 were significantly lower in the ICH+LEV group than in the control group (P<0.05). CONCLUSIONS: Our study suggests that treatment with LEV alleviates early inflammatory responses induced by ICH. Mechanistically, LEV inhibited the JAK2-STAT3 signaling pathway and reduced neuronal injury around the hematoma, and ameliorated brain edema, all of which promoted recovery of nerve function after hemorrhage. International Scientific Literature, Inc. 2020-04-14 /pmc/articles/PMC7174898/ /pubmed/32289810 http://dx.doi.org/10.12659/MSM.922741 Text en © Med Sci Monit, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Animal Study
Xiong, Jing
Zhou, Han
Lu, Donglin
Wang, Zixuan
Liu, HengJian
Sun, Yuqi
Xu, Jinxiang
Feng, Yugong
Xing, Ang
Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
title Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
title_full Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
title_fullStr Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
title_full_unstemmed Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
title_short Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)–Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
title_sort levetiracetam reduces early inflammatory response after experimental intracerebral hemorrhage by regulating the janus kinase 2 (jak2)–signal transducer and activator of transcription 3 (stat3) signaling pathway
topic Animal Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174898/
https://www.ncbi.nlm.nih.gov/pubmed/32289810
http://dx.doi.org/10.12659/MSM.922741
work_keys_str_mv AT xiongjing levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT zhouhan levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT ludonglin levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT wangzixuan levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT liuhengjian levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT sunyuqi levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT xujinxiang levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT fengyugong levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway
AT xingang levetiracetamreducesearlyinflammatoryresponseafterexperimentalintracerebralhemorrhagebyregulatingthejanuskinase2jak2signaltransducerandactivatoroftranscription3stat3signalingpathway